Novartis Vaccines

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 694 490
Fax: +44 (0)1276 698 460
WWW: http://www.novartis.com
Medical Information Direct Line: +44 (0)8457 451 500
Medical Information e-mail: serviceuk@novartis.com
Medical Information Fax: +44 (0)1517 055 669
Summary of Product Characteristics last updated on the eMC: 09/09/2009
SPC Begrivac 2009/2010 suspension for injection in pre-filled syringe

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 09/09/2009 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and Lactation
  • Change to section 10 date of revision of the text
  • Change to section 2 - Qualitative and quantitative composition
Date of revision of text on the SPC:   01-May-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

- section 2...the strains are revised to take account of those recommended for the 2009/2010 flu season
- in sections 4.1 - 4.6,,,,,the new season (Begrivac 2009/2010) replaces the previous season (2009/2009)
- section 10 provides the date of the latest revision of the text
Updated on 27/08/2008 and displayed until 09/09/2009
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   01-May-2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

- In section 2 (qualitative and quanititative composition), antigens updated for 2008-2009 season
- In section 10 (date of partial revision of the text), date updated to incorporate new antigen strains for 2008-2009 season
Updated on 05/11/2007 and displayed until 27/08/2008
Reasons for adding or updating:
  • Change to section 1 -Name of the Medicinal product
  • Change to section 2 - Qualitative and quantitative composition
Date of revision of text on the SPC:   05/2007
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

section 1: update vaccine season to 2007/2008
Section 2 : update composition of viral strains of influenza vaccine to 2007/2008 season
Updated on 25/10/2006 and displayed until 05/11/2007
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

Active Ingredients/Generics

 
   influenza vaccine


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk